Harmony Capital (530055)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Reported profit growth of 85.71% suggests some improvement from a weak base, though 85.71% can mislead with near-zero earnings.
• Piotroski F-Score of 5/9 is not a distress score and implies moderate financial health.
• Debt/Equity is N/A, so the balance sheet does not appear burdened by leverage in the disclosed figures.
• Tiny ₹12 Cr market cap means even small absolute changes can produce large reported percentage movements.

Concerns

• P/B of 10.78 against book value of ₹3.57 means investors pay over ten times assets for a business earning negative ROE of -22.56%.
• ROCE of -57.69% indicates severe capital inefficiency and ongoing value destruction.
• Latest quarter shows ₹0 Cr sales and ₹-0 Cr net profit, so there is no visible revenue-generating business.
• No dividend, P/E of 0.00, and current price below the stated 52-week low of ₹58.00 raise serious red flags about valuation and liquidity.

AI Analysis

With Harmony Capital, I start with the most basic question: what does this business earn? The answer is essentially nothing. The latest quarter shows ₹0 Cr in sales and ₹-0 Cr in net profit. The P/E of 0.00 is not a valuation; it is an absence of earnings. Book value is ₹3.57 per share, yet the market price is ₹38.48, so I am paying 10.78 times book. That would only be rational for a wonderful high-return business, but ROE is minus 22.56% and ROCE is minus 57.69%. This is capital destruction, not compounding. The reported 85.71% profit growth sounds dramatic, but without a positive base and with zero sales, I cannot treat it as genuine growth. There is no dividend, so I am entirely dependent on price appreciation. I see no moat in 'diversified commercial services'—a description that often hides a company doing little of anything. The Piotroski score of 5/9 is mediocre, not a sign of strength. The stock is a ₹12 crore microcap, and the current quote is below the stated 52-week low of ₹58.00, which tells me liquidity and data quality deserve extra caution. Benjamin Graham taught me to buy with a margin of safety. Here, the margin of safety is missing: a negative return on capital, no earnings, and a heavy premium to book. This is not a stalwart or a grower. It is, at best, a speculative turnaround that requires evidence of a real operating recovery. I will wait until the numbers prove themselves.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer